STOCK TITAN

INHIBITOR THERAPTICS INC (INTI) EPS by Year

INTI

INHIBITOR THERAPTICS INC lost $0.02 per diluted share in fiscal year 2025. That is unchanged from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a loss of $0.01 per diluted share. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters INHIBITOR THERAPTICS INC has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.02
YoY 0.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INTI EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
EPS (Diluted)-$0.01-$0.020.0%-$0.020.0%-$0.02$0.03$0.00N/AN/AN/AN/AN/AN/AN/A-$0.10-1100.0%$0.01

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

INTI EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)$0.00$0.00-$0.010.0%$0.00$0.00$0.00-$0.010.0%$0.00$0.00$0.00-$0.01-133.3%$0.00

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More INHIBITOR THERAPTICS INC financials

Frequently Asked Questions

What was INHIBITOR THERAPTICS INC's diluted earnings per share in fiscal year 2025?

INHIBITOR THERAPTICS INC lost $0.02 per diluted share in fiscal year 2025.

How fast is INHIBITOR THERAPTICS INC's diluted earnings per share growing?

INHIBITOR THERAPTICS INC (INTI) diluted earnings per share was essentially unchanged year over year, at -$0.02 in fiscal year 2025 against -$0.02 the year before.

What is INHIBITOR THERAPTICS INC's diluted earnings per share over the last twelve months?

INHIBITOR THERAPTICS INC (INTI) reported a loss of $0.01 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 14 fiscal years this page covers, INHIBITOR THERAPTICS INC (INTI) diluted earnings per share went from $0.01 in fiscal year 2012 to -$0.02 in fiscal year 2025.

INHIBITOR THERAPTICS INC (INTI) reported $0.00 in diluted earnings per share in Q2 2026.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what INHIBITOR THERAPTICS INC (INTI) reported on that line in every period on record.